Latest Tax Incentives News

Right Resources Limited has secured over A$1.1 million in R&D-related funding, advancing its geological research and mineralisation modelling in NSW’s Tumbarumba district through a strategic partnership with the University of Tasmania’s CODES.

Hastings Technology Metals has acquired a 49% stake in a fully permitted rare earth processing plant in Thailand, aiming to commence production by late 2026. This strategic move offers a lower-cost, near-term production hub with potential to process feedstock from its Yangibana project.

State Gas Limited has decided against proceeding with the sale of its High Density Natural Gas Pilot Plant after failing to finalise terms, while its R&D tax incentive claim remains under extended review by the ATO.

Barton Gold Holdings has secured a $520,000 cash refund through the Federal Government’s R&D Tax Incentive, bolstering its exploration efforts in South Australia’s emerging gold province.

Sparc Technologies has secured a $680,000 non-dilutive advance on its anticipated FY26 R&D tax refund, strengthening its cash flow as it accelerates commercialisation of its graphene additive ecosparc and green hydrogen ventures.

Advanced Energy Minerals is ramping up production capacity at its Quebec plant, leveraging patented low-cost technology and renewable energy to meet booming global demand for high purity alumina.

Argenica Therapeutics has secured a nearly $4 million R&D tax incentive rebate for FY25, strengthening its cash position as it prepares for a pivotal Phase 2b trial of its neuroprotective peptide ARG-007.

Resonance Health has received a $732,851 refund from the Australian Taxation Office, reflecting its FY2025 R&D tax incentive claim net of income tax payable. This cash inflow strengthens the company’s financial position ahead of its March quarterly report.

Elixir Energy has completed drilling the Lorelle-3H well in Queensland’s Taroom Trough, achieving over 1,000 metres of high-quality net gas-condensate pay and setting a new benchmark for lateral drilling in the basin. A multi-stage fracture stimulation and production test is planned for Q2 2026, potentially paving the way for Elixir’s first reserves booking.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.

Janus Electric has locked in a $2.75 million R&D finance facility, strengthening its cash position to push forward with its zero-emission transport innovations. This strategic funding avoids shareholder dilution while supporting ongoing technology development.

Entropy Neurodynamics has received a $1.73 million R&D tax incentive refund from the Australian Government, reinforcing its clinical development of an intravenous psilocin treatment for neuropsychiatric disorders.